Meca-Lallana JE, Fernandez-Prada M, Garcia Vazquez E, Moreno Guillen S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueno S, Fernandez Fernandez O, Izquierdo Ayuso G, Alvarez Cermeno JC, Arnal Garcia C, Arroyo Gonzalez R, Brieva Ruiz L, Calles Hernandez C, Garcia Merino A, Gonzalez Platas M, Hernandez Perez MA, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto Gonzalez JM, Ramio-Torrenta L, Rodriguez-Antiguedad A, Saiz A, Tintore M, Montalban Gairin X. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain. Neurologia (Engl Ed). 2020 Jan 25;37(8):615-630. doi: 10.1016/j.nrl.2019.11.003. Print 2022 Oct. English, Spanish. PubMed PMID: 31987648.
AÑO: 2022; IF: 3.109
